IP, R&D & Innovation Insights Newsletter - Patsnap

AI
Product
- IP Intelligence
  
  Patent Analytics
- R&D Intelligence
  
  Patsnap Eureka
  
  Patsnap Eureka Materials
  
  Discovery
- Life Sciences Intelligence
  
  Synapse
  
  Bio
  
  Chemical
- Other Services
  
  Data Service
  
  Professional Services
Pricing
Solutions
- Law firms
- Life Sciences
Resources
Company

Patsnap Surpasses US$100 Million in Annual Recurring Revenue

Patsnap has reached a significant milestone of achieving $100M in Annual Recurring Revenue (ARR), marking an impressive 20% year-over-year growth in 2023. This milestone highlights the massive and meaningful value our platform brings to over 12,000 IP and R&D teams across 50 countries, driving efficiency, productivity, and collaboration.